Brochure
13 Feb 2019
API development and manufacturing presentation
PDF 4.4 MB
Content provided by our supplier
Orion Corporation
-
FI -
2015On CPHI since
-
2Certificates
-
250 - 499Employees
Company types
Primary activities
Other Content from Orion Corporation (1)
-
News Bayer and Orion (Fermion) experiences in development of API process for Darolutamide
The compound was first synthesized and developed by Orion, who partnered it with Bayer for Phase III clinical development. Bayer holds the global marketing rights, while Orion and its subsidiary Fermion handle all the CMC and manufacturing activities from early clinical development to commercial production. Orion manufactures the drug products, while Fermion manufactures the Darolutamide API. Orion holds co-promotion rights for Europe.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance